Cutter Capital Management, LP Biogen Inc. Transaction History
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
A detailed history of Cutter Capital Management, LP transactions in Biogen Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 76,726 shares of BIIB stock, worth $15.3 Million. This represents 5.37% of its overall portfolio holdings.
Number of Shares
76,726
Previous 52,000
47.55%
Holding current value
$15.3 Million
Previous $11.2 Billion
58.63%
% of portfolio
5.37%
Previous 4.29%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.31 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.26 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.9 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.41 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.13 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $28.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...